Table 3.
Variable | Change in CA125 from Baseline to 3 months N (%) | P | |||
---|---|---|---|---|---|
Normal to Normal | High to Normal | Normal to High | High to High | ||
Prior Treatment History | |||||
• Previously treated disease | 15 (60) | 17 (50) | 6 (100) | 96 (91.4) | <0.001 (chi-square) |
• Newly diagnosed | 10 (40) | 17 (50) | 0 (0) | 9 (8.6) | |
Stage at Diagnosis | |||||
• Stage I | 10 (40) | 4 (14.3) | 0 (0) | 11 (10.9) | |
• Stage II | 2 (8) | 6 (21.4) | 0 (0) | 7 (6.9) | 0.009 (chi- square) |
• Stage III | 11 (44) | 15 (53.6) | 5 (83.3) | 75 (74.3) | |
• Stage IV | 2 (8) | 3 (10.7) | 1 (16.7) | 8 (7.9) | |
Mean (Standard Deviation) | |||||
Age at presentation | 52.3 (12.9) | 55.4 (11.5) | 54.1 (6.3) | 52.9 (10.2) | 0.67 (ANOVA) |